Alexion Pharmaceuticals Inc.

NASDAQ:ALXN   3:59:41 PM EDT
121.51
+1.84 (+1.54%)
Share Repurchases, Other Pre-Announcement

Alexion Pharmaceuticals Inc Says Expect To Raise 2020 FullYear Revenue Guidance By $200 Million

Published: 10/06/2020 11:18 GMT
Alexion Pharmaceuticals Inc (ALXN) - Alexion Pharmaceuticals Inc - Expect to Raise 2020 Full-year Revenue Guidance by >$200 Million.
Alexion Pharmaceuticals Inc - Expected to Return About $3 Billion Cash to Shareholders Through 2023 Through Repurchases.
Alexion Pharmaceuticals Inc - Anticipated 2025 Global Revenue Target of $9 to $10 Billion.
Alexion Pharmaceuticals Inc Sees at Least 10 Percent Revenue Compound Annual Growth Rate (cagr) Through 2025 and Beyond.